For instance, [68Ga]Ga-FAPI-04, a quinoline-based FAP-targeting tracer [26], has been shown to have faster pharmacokinetics, higher tumor uptake, and superior tumor-to-background contrast in patients with various cancers when compared with [18F]FDG [27]. This evidence concerns the gene FAP and neoplasm.